Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Bo Hu(Central South University), Shengyuan Yu(Nankai University), Xiang Li(Shandong University), Gang Li(Tongji University), Xiaohong Li(Shandong University), Junpeng Zhuang(Lilly (China)), Hongru Zhao(Soochow University), Zhihua Jia(Chinese PLA General Hospital), Shan Wu(Jilin University), Tingmin Yu(Second Affiliated Hospital of Jilin University)
Cited by 37
Related Papers
Microglia-derived TNF-α mediates endothelial necroptosis aggravating blood brain–barrier disruption after ischemic stroke
|Cell Death and Disease|2019|551
China stroke surveillance report 2021
|Military Medical Research|2023|525
Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer
|Proceedings of the National Academy of Sciences|2013|329
LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
|Cell Death and Disease|2019|207
Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke
|New England Journal of Medicine|2024|162